Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Psycho-Oncology|November 13, 2023
Psychological distress and mental health care utilization among Hispanic/Latino survivors of adolescent and young adult cancerEunju Choi, Amy M Berkman, Christabel K Cheung, et al.
JNCI Cancer Spectrum|June 27, 2025
Risk of early death after acute leukemia diagnosis among adolescents and young adultsAmy M Berkman, Clark R Andersen, Vidya Puthenpura, et al.
Cell Reports|January 27, 2021
Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcomaRicha Rathore, Katharine E Caldwell, Charles Schutt, et al.
Practical Radiation Oncology|January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue SarcomaAndrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
American Journal of Clinical Oncology|September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Rare Tumors|August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohortMichael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2023
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse OutcomesRyan A Denu, Richard K Yang, Alexander J Lazar, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient SelectionAhsan S Farooqi, Alison K Yoder, Heather Y Lin, et al.
Cancers|May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center ExperienceLewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Pageof 9